Skip to main content
. 2016 Dec;12(4):403–413. doi: 10.2174/1573399812666151223093841

Table 1.

Number of abstracts reporting adverse events at the ADA, AACE, and EASD, 2010-2014.

Exenatide BID and LAR Liraglutide Albiglutide Dulaglutide
ADA AACE EASD ADA AACE EASD ADA AACE EASD ADA AACE EASD
Nausea 30 1 30 24 1 22 16 0 8 5 0 5
Constipation 1 0 1 1 0 0 0 0 0 0 0 0
Vomiting 15 2 15 15 0 15 16 0 8 2 0 4
Diarrhea 11 0 13 6 1 9 11 0 8 4 0 5
Dyspepsia 0 0 0 2 0 1 0 0 0 1 0 1
Injection-site reaction 6 1 10 2 1 3 16 0 9 0 0 1
Headache 2 0 4 1 0 0 0 0 0 0 0 0
Respiratory 4 0 3 2 0 2 1 0 0 0 0 0
Asthenia 0 0 0 0 0 0 0 0 0 0 0 1

aThe adverse events selected for these searches are the ones listed in the prescribing information documents for each of drugs.